packageVandetanib

vandetanib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Vandetanib is a protein kinase inhibitor used to treat thyroid cancer, especially medullary thyroid carcinoma. It is an approved medicine and remains authorised in the European Union, though it carries a boxed warning.

Summary written by glm-5.3-flash from Wikidata Q7914515 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:vandetanib
ATC codes:L01EX04, L01XE
DrugBank:DB05294
PubChem CID:3081361
ChEBI:49960
Wikidata:Q7914515
formula:C22H24BrFN4O2
molar mass:475.362 g/mol (PubChem CID 3081361)
logP:4.9 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown